Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma

Pancreas

Volumn 19, Issue 4, 1999, Pages 353-361

  Mohammad, Ramzi M ^a   Li, Yiwei ^a   Mohamed, Anwar N ^a   Pettit, George R ^b   Adsay, Volkan ^a   Vaitkevicius, Vainutis K ^a   Al Katib, Ayad M ^a   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Auristatin PE; Bryostatin 1; Gemcitabine; Human pancreatic cell line; KCI MOH1; SCID mice; Spongistatin 1; Xenograft

Indexed keywords

ANTINEOPLASTIC AGENT; AURISTATIN PE; BRYOSTATIN 1; GEMCITABINE; SPONGISTATIN 1; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER REGRESSION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PRESERVATION; PRIORITY JOURNAL; TUMOR XENOGRAFT;

EID: 0032759375     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199911000-00006     Document Type: Article

References (18)

1. Parker SL, Tong T. Bolen S, Wingo PA. Cancer statistics. CA Cancer J Clin 1997;47:5-27.
2. Gudjonnson B. Carcinoma of the pancreas. 50 years of surgery. Cancer 1987;60:2284-303.
3. Casper ES, Kelsen DP. Adenocarcinoma of the pancreas: overview of workup and management. Adv Oncol 1995;11:17-22.
4. Kelly DM, Benjamin IS. Pancreatic carcinoma. Ann Oncol 1995; 6:19-28.
5. Grindey GB, Hertel LW, Plunkett W. Cytotoxicity and antitumor activity of 2′2′-difluorodeoxycytidine (Gemcitabine). Cancer Invest 1990;8:313-8.
6. Rothenberg ML, Moore MJ, Cripps MC, et al. A phase II trial of Gemcitabine in patients with 5-FU refractory pancreas cancer. Ann Oncol 1996;7:347-53.
7. Pettit GR, Herald CL, Doubek DL, Herald DL, Arnold E, Clardy J. Isolation and structure of bryostatin 1. J Am Chem Soc 1982; 104:6846-8.
8. Mohammad RM, Dugan MC, Mohamed AN, et al. Establishment of a human pancreatic xenograft model: potential application for preclinical evaluation of novel therapeutic agents. Pancreas 1998; 16:19-25.
9. Mohammad RM, AlKatib A, Pettit GR, Sensenbrenner LL. Successful treatment of human Waldenstrom's macroglobulinemia with combination biological and chemotherapy agents. Cancer Res 1994;54:165-8.
10. Pettit GR, Srirangam JK, Barkoczy J, et al. Antineoplastic agents 337: synthesis of dolastatin 10 structural modifications. Anticancer Drug Design 1995;10:529-44.
11. Pettit GR. The dolastatins. In: Herz W, Kirby GW, Moore RE, Steglich W, Tamm CH, eds. Progress in the chemistry of organic natural products. New York: Springer Verlag, 1987:263.
12. Sarkar FH, Li YW, Crissman JD. A method for PCR sequencing of the p53 gene from a single 10 μm frozen paraffin-embedded tissue section. Biotechniques 1993;15:37.
13. Mohamed AN, Wolman SR. Chromosome analysis in cell culture. In: Studzinski G. ed. Cell growth and apoptosis: a practical approach. 2nd ed. New York: Oxford University Press, 1995:79-96.
14. Pettit GR, Cichacz ZA, Gao F, et al. Isolation and structure of spongistatin 1. J Org Chem 1993;58:1302-4.
15. Mohammad RM, Varterasian ML, Almatchy VP, Hannoudi GN, Pettit GR, AlKatib A. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1. Clin Cancer Res 1998;4:1337-43.
16. Corbett TH, Valeriote FA, Polin L, et al. Discovery of solid tumor activity agents using a soft agar colony formation disk diffusion assay. In: Valeriote F, Corbett T, Baker L, eds. Cytotoxic anticancer drugs: models and concepts for drug discovery and development. Boston: Kluwer Academic Publishers, 1992:35-89.
17. Schuchter LM, Esa AH, May S, Laulis MK, Pettit GR, Hess AD. Successful treatment of murine melanoma with bryostatin 1. Cancer Res 1991;51:682-7.
18. Kennedy MJ, Prestigiacomo LJ, Tyler G, et al. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Cancer Res 1992;52:1278-83.